**10. References**


Abendroth, A. & Arvin, A. (1999). Varicella-zoster virus immune evasion. *Immunol Rev*, Vol.

Arvin, A. M. (1996). Varicella-zoster virus. *Clin Microbiol Rev*, Vol. 9, No. 3, (July 1996), pp.

Arvin, A. M. (2001). Varicella vaccine: genesis, efficacy, and attenuation. *Virology*, Vol. 284,

Arvin, A. M. (2006). Investigations of the pathogenesis of varicella zoster virus infection in

Arvin, A. M., Moffat, J. F., Sommer, M., Oliver, S., Che, X., Vleck, S., Zerboni, L., & Ku, C. C.

Besser, J., Sommer, M. H., Zerboni, L., Bagowski, C. P., Ito, H., Moffat, J., Ku, C. C., & Arvin,

Burgoon, C. F., Burgoon, J. S., & Baldridge, G. D. (1957). The natural history of herpes zoster.

Cohen, J. I. & Seidel K. E. (1993). Generation of Varicella-Zoster Virus (VZV) and Viral

Cohen, J. I. & Seidel, K. (1994). Varicella-zoster virus (VZV) open reading frame 10 protein,

Cohen, J. I. & Seidel, K. E. (2001). Varicella-zoster virus and its replication, In: *Fields Virology* 

Cohen, J. , Straus, S., & Arvin, A. (2007). Varicella-Zoster Virus Replication, Pathogenesis,

Defechereux, P., Melen, L., Baudoux, L., Merville-Louis, M. P., Rentier, B., & Piette, J.

*J Am Med Assoc*, Vol. 164, No. 3, (May 1957), pp. 265-269

Wilkins, ISBN 0-7818-1832-5, Philadelphia, PA

the SCIDhu mouse model. *Herpes*, Vol. 13, No. 3, (November 2006), pp. 75-80, ISSN

(2010). Varicella-zoster virus T cell tropism and the pathogenesis of skin infection. *Curr Top Microbiol Immunol*, Vol. 342, (September 2010), pp. 189-209, ISSN 0070-217X Bernstein, H. H., Rothstein, E. P., Watson, B. M., Reisinger, K. S., Blatter, M. M., Wellman, C.

O., Chartrand, S. A., Cho, I., Ngai, A., & White, C. J. (1993). Clinical survey of natural varicella compared with breakthrough varicella after immunization with live attenuated Oka/Merck varicella vaccine. *Pediatrics*, Vol. 92, No. 6, (December

A. M. (2003). Differentiation of varicella-zoster virus ORF47 protein kinase and IE62 protein binding domains and their contributions to replication in human skin xenografts in the SCID-hu mouse. *J Virol*, Vol. 77, No. 10, (May 2003), pp. 5964-

Mutants from Cosmid DNAs - VZV Thymidylate Synthetase Is Not Essential for Replication in-Vitro. *Proc Natl Acad Sci USA*, Vol. 90, No. 15, (August 1993), pp.

the homolog of the essential herpes simplex virus protein VP16, is dispensable for VZV replication in vitro. *J Virol*, Vol. 68, No. 12, (December 1994), pp. 7850-7858,

(4th ed.), D. M. Knipe & P. M. Howley, pp. 2707-2730, Lippincott Williams &

and Management, In: *Fields Virology* (5th ed.), D. M. Knipe & P. M. Howley, pp. 2744-2818, Lippincott Williams & Wilkins, ISBN 0-7817-6060-7, Philadelphia, PA Contag, C. H., Spilman, S. D., Contag, P. R., Oshiro, M., Eames, B., Dennery, P., Stevenson,

D. K., & Benaron, D. A. (1997). Visualizing gene expression in living mammals using a bioluminescent reporter. *Photochem Photobiol*, Vol. 66, No. 4, (October 1997),

(1993). Characterization of the regulatory functions of varicella-zoster virus open

168, (April 1999), pp. 143-156, ISSN 0105-2896

No. 2, (June 2001), pp. 153-158, ISSN 0042-6822

1993), pp. 833-837, ISSN 0031-4005

5974, ISSN 0022-538X

7376-7380, ISSN 0027-8424

pp. 523-531, ISSN 0031-8655

ISSN 0022-538X

361-381, ISSN 0893-8512

0969-7667

**10. References** 

reading frame 4 gene product. *J Virol*, Vol. 67, No. 7, (July 1993), pp. 4379-4385, ISSN 0022-538X


Ku, C. C., Besser, J., Abendroth, A., Grose, C., & Arvin, A. M. (2005). Varicella-zoster virus

Kurfurst, M., Ghisla, S., & Hastings, J. W. (1983). Bioluminescence emission from the

Lydick, E., Epstein, R. S., Himmelberger, D., & White, C. J. (1995). Herpes zoster and quality

Mallory, S., Sommer, M., & Arvin, A. M. (1997). Mutational analysis of the role of

Mallory, S., Sommer, M., & Arvin, A. M. (1998). Analysis of the glycoproteins I and E of

Marchini, A., Liu, H., & Zhu, H. (2001). Human Cytomegalovirus with IE-2 (UL122) Deleted

Miwa, N., Kurosaki, K., Yoshida, Y., Kurokawa, M., Saito, S., & Shiraki, K. (2005).

Moffat, J. F. & Arvin, A. M. (1999). Varicella-zoster virus infection of T cells and skin in the

Moriuchi, H., Moriuchi, M., Straus, S. E., & Cohen, J. I. (1993). Varicella-zoster virus (VZV)

Moriuchi, H., Moriuchi, M., Smith, H. A., & Cohen, J. I. (1994). Varicella-zoster virus open

Nagaike, K., Mori, Y., Gomi, Y., Yoshii, H., Takahashi, M., Wagner, M., Koszinowski, U., &

Niizuma, T., Zerboni, L., Sommer, M. H., Ito, H., Hinchliffe, S., & Arvin, A. M. (2003).

*Dis*, Vol. 178, Suppl. 1, (November 1998), S22-26, ISSN 0022-1899

*J Virol*, Vol. 72, No. 2, (February 1998), pp. 965-974, ISSN 0022-538X

No. 7, (March 1983), pp. 1521-1525, ISSN 0006-2960

(December 1995), S52-53, ISSN 0028-3878

ISSN 0022-538X

8288, ISSN 0022-538X

1870-1878, ISSN 0022-538X

ISBN 978-0-12-775390-4, San Diego, CA

pp. 1987-1992, ISSN 0022-538X

(September 2004), pp. 4069-4074, ISSN 0264-410X

0022-538X

pathogenesis and immunobiology: new concepts emerging from investigations with the SCIDhu mouse model. *J Virol*, Vol. 79, No. 5, (March 2005), pp. 2651-2658,

reaction of luciferase-flavin mononucleotide radical with O2. *Biochemistry*, Vol. 22,

of life: a self-limited disease with severe impact. *Neurology*, Vol. 45, No. 12, Suppl. 8,

glycoprotein I in varicella-zoster virus replication and its effects on glycoprotein E conformation and trafficking. *J Virol*, Vol. 71, No. 11, (November 1997), pp. 8279-

varicella-zoster virus (VZV) using deletional mutations of VZV cosmids. *J Infect* 

Fails To Express Early Lytic Genes. *J. Virol*, Vol. 75, No. 4, (February 2001), pp.

Comparative efficacy of acyclovir and vidarabine on the replication of varicellazoster virus. *Antiviral Res*, Vol. 65, No. 1, (January 2005), pp. 49-55, ISSN 0166-3542 Moffat, J. F., Zerboni, L., Kinchington, P. R., Grose, C., Kaneshima, H., & Arvin, A. M. (1998).

Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse.

SCID-hu mouse model, In *Handbook of animal models of infection: experimental models in antimicrobial chemotherapy*, M. A. Sande & O. Zak, pp. 973-980, Academic Press,

open reading frame 61 protein transactivates VZV gene promoters and enhances the infectivity of VZV DNA. *J Virol*, Vol. 67, No. 7, (July 1993), pp. 4290-4295, ISSN

reading frame 4 protein is functionally distinct from and does not complement its herpes simplex virus type 1 homolog, ICP27. *J Virol*, Vol. 68, No. 3, (March 1994),

Yamanishi, K. (2004). Cloning of the varicella-zoster virus genome as an infectious bacterial artificial chromosome in Escherichia coli. *Vaccine*, Vol. 22, No. 29-30,

Construction of Varicella-Zoster Virus Recombinants from Parent Oka Cosmids and Demonstration that ORF65 Protein Is Dispensable for Infection of Human Skin and T Cells in the SCID-hu Mouse Model. *J. Virol*, Vol. 77, No. 10, (May 2003), pp. 6062-6065, ISSN 0022-538X

